Small cell lung cancer is an aggressive histologic subtype of lung cancer in which the role of chemotherapy and radiotherapy has been well established in limited-stage disease. We retrospectively reviewed a series of limited-stage small cell lung cancers treated with chemotherapy and thoracic and brain radiotherapy.
Methods and Study Design
A total of 124 patients affected by limited-stage small cell lung cancer has been treated over 10 years in our Institute. Fifty-three patients (42.8%) had concomitant radio-chemotherapy treatment and 71 patients (57.2%) a sequential treatment. Eighty-eight patients (70.9%) underwent an association of a platinum-derived drug (cisplatinum or carboplatinum) and etoposide. Prophylactic cranial irradiation was planned in all patients with histologically proven complete response to primary radio-chemotherapy.
Results
With a mean follow-up of 2.2 years, complete response was obtained in 50.8% of cases. We found a significant difference between different radio-chemotherapy association approaches (P = 0.007): percentages of overall survival were respectively 10.0%, 12.9% and 5.6% in early, late concomitant and sequential radiochemotherapy timing. Cranial prophylaxis did not seem to influence overall survival (P = 0.21) or disease-free survival for local relapse (P = 0.34).
Conclusions
Concomitant radio-chemotherapy is the best approach according to our experience. Our results show a benefit of prophylactic cranial irradiation in distant metastasis-free survival.
LowenbraunS., BartolucciA., SmalleyR.V., LynnM., KraussS., DurantJ.R.: The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma. Cancer, 44: 406–413, 1979.
2.
McCrackenJ.D., JanakiL.M., CrowleyJ.J., TaylorS.A., GiriP.G., WeissG.B., GordonWJr, BakerL.H., MansouriA., KueblerJ.P.: Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma. A Southwest Oncology Group Study. J Clin Oncol, 8: 892–898, 1990.
3.
WardeP., PayneD.: Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol, 10: 890–895, 1992.
4.
PignonJ.P., ArriagadaR., IhdeD.C., JohnsonD.H., PerryM.C., SouhamiR.L., BrodinO., JossR.A., KiesM.S., LebeauB.: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med, 327: 1818–1824, 1992.
5.
StinchcombeT.E., GoreE.M.: Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. Oncologist, 15: 187–195, 2010.
6.
SenanS., De RuysscherD., GiraudP., MirimanoffR., BudachV.: Radiotherapy Group of European Organization for Research and Treatment of Cancer. Literature-based recommendations for treatment planning and execution in highdose radiotherapy for lung cancer. Radiother Oncol, 71: 139–146, 2004.
7.
BentzenS.M., ConstineL.S., DeasyJ.O., EisbruchA., JacksonA., MarksL.B., Ten HakenR.K., YorkeE.D.: Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys, 76(3 Suppl): S3–9, 2010.
8.
ArriagadaR., Le ChevalierT., BorieF., RivièreA., ChomyP., MonnetI., TardivonA., ViaderF., TarayreM., BenhamouS.: Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst, 87: 183–190, 1995.
9.
ScottiV., MeattiniI., SaievaC., RampiniA., De Luca CardilloC., BastianiP., MangoniM., AgrestiB., SantomaggioC., Di CataldoV., FranzeseC., LiviL., MagriniS.M., BitiG.: Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy. Tumori, 98: 53–59, 2012.
10.
RubinsJ., UngerM., ColiceG.L.: American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest, 132 (3 suppl): 355S–367S, 2007.
BaymanN.A., SheikhH., KularatneB., LoriganP., BlackhallF., ThatcherN., Faivre-FinnC.: Radiotherapy for small-cell lung cancer-Where are we heading?Lung Cancer, 63: 307–314, 2009.
14.
HuX., BaoY., ZhangL., GuoY., ChenY.Y., LiK.X., WangW.H., LiuY., HeH., ChenM.: Omitting elective nodal irradiation and irradiating postinduction versus preinduction chemotherapy tumor extent for limited-stage small cell lung cancer: interim analysis of a prospective randomized noninferiority trial. Cancer, 118: 278–287, 2012.
15.
JohnsonB.E., BridgesJ.D., SobczeckM., GrayJ., LinnoilaR.I., GazdarA.F., HankinsL., SteinbergS.M., EdisonM., FrameJ.N., PassH., NesbittJ., HoldenD., MulshineJ.L., GlatsteinE., IhdeD.C.: Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol, 14: 806–813, 1996.
16.
TurrisiA.T., GloverD.J., MasonB.A.: A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer. Int J Radiat Oncol Biol Phys, 15: 183–187, 1988.
17.
MurrayN., CoyP., PaterJ.L., HodsonI., ArnoldA., ZeeB.C., PayneD., KostashukE.C., EvansW.K., DixonP.: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol, 11: 336–344, 1993.
18.
JeremicB., ShibamotoY., AcimovicL., MilisavljevicS.: Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol, 15: 893–900, 1997.
19.
TakadaM., FukuokaM., KawaharaM.: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol, 20: 3054–3060, 2002.
20.
SpiroS.G., JamesL.E., RuddR.M.: Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol, 24: 3823–3830, 2006.
21.
ArriagadaR., Le ChevalierT., BorieF., RivièreA., ChomyP., MonnetI., TardivonA., ViaderF., TarayreM., BenhamouS.: Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst, 87: 183–190, 1995.
22.
AupérinA., ArriagadaR., PignonJ.P.: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med, 341: 476–484, 1999.
23.
MeertA.P., PaesmansM., BerghmansT., MartinB., MascauxC., VallotF., VerdeboutJ.M., LafitteJ.J., SculierJ.P.: Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer, 1: 5, 2001.
24.
PatelS., MacDonaldO.K., SuntharalingamM.: Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Cancer, 115: 842–850, 2009.
25.
GiulianiM., SunA., BezjakA., MaC., LeL.W., BradeA., ChoJ., LeighlN.B., ShepherdF.A., HopeA.J.: Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. Cancer, 116: 5694–5699, 2010.
26.
Le PéchouxC., LaplancheA., Faivre-FinnC., CiuleanuT., WandersR., LerougeD., KeusR., HattonM., VideticG.M., SenanS., WolfsonA., JonesR., ArriagadaR., QuoixE., DunantA.; Prophylactic Cranial Irradiation (PCI) Collaborative Group: Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99–01, EORTC 22003–08004, RTOG 0212 and IFCT 99–01). Ann Oncol, 22: 1154–1163, 2011.
27.
SlotmanB., Faivre-FinnC., KramerG., RankinE., SneeM., HattonM., PostmusP., ColletteL., MusatE., SenanS.; EORTC Radiation Oncology Group and Lung Cancer Group: Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med, 357: 664–672, 2007.
28.
SchildS.E., FosterN.R., MeyersJ.P., RossH.J., StellaP.J., GarcesY.I., OlivierK.R., MolinaJ.R., PastL.R., AdjeiA.A.; North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: Findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol, 23: 2919–2924, 2012.
29.
Sas-KorczynskaB., KorzeniowskiS., WójcikE.: Comparison of the effectiveness of “late” and “early” prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. Strahlenther Onkol, 186: 315–319, 2010.
30.
Prophylactic Cranial Irradiation Overview Collaborative Group: Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission. Cochrane Database Syst Rev. (4): CD002805, 2000.
